Amphetamine use down among US workers

25 June 2006

Amphetamine use, which includes amphetamine and methamphetamine, declined significantly among general US workforce employees during 2005, according to the semi-annual Drug Testing Index, released June 19 by Quest Diagnostics, a provider of employer drug testing services in the USA.

The 2005 Drug Testing Index summarizes the results of workplace drug tests performed by Quest Diagnostics between January and December 2005. Federally-mandated, safety-sensitive workers include pilots, bus and truck drivers and workers in nuclear power plants, for whom routine drug testing is mandated by the US Department of Transportation and the Nuclear Regulatory Commission.

In 2005, the incidence of amphetamines drug-test positives declined 8% to 0.48% of all drug tests of general US workforce employees that identify amphetamines use. During 2004 amphetamines drug-test positives were 0.52%. Among federally-mandated, safety-sensitive workers, the positivity rate for amphetamines rose 13% to 0.35% in 2005 from 0.31% in 2004

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight